And by your book , Nuix’s US competitor Palantir at Nasdaq should have been trashed , binned , and doomed to hell with a “horrible” show of negative earning. And Palantir “disappointed” the market by a current market cap of $US 46.6b with a revenue of $1.1B . Bear in mind Nuix is making money and operates in the US market as well. Yes, there are hypes but that’s the market, some people can’t stand the heat so they choose to stay out of the kitchen. But some they choose to stay in the kitchen whinging on why people are turning up the gas while standing there salivating over a meal that could either go bang or go sour.
- Forums
- ASX - By Stock
- NXL
- $7 party
$7 party, page-43
-
- There are more pages in this discussion • 235 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NXL (ASX) to my watchlist
(20min delay)
|
|||||
Last
$3.39 |
Change
-0.110(3.14%) |
Mkt cap ! $1.096B |
Open | High | Low | Value | Volume |
$3.47 | $3.52 | $3.37 | $2.621M | 764.7K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
13 | 3248 | $3.38 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$3.39 | 2428 | 8 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
31 | 11913 | 3.370 |
17 | 6156 | 3.360 |
11 | 35380 | 3.350 |
5 | 4569 | 3.340 |
7 | 27612 | 3.330 |
Price($) | Vol. | No. |
---|---|---|
3.380 | 3444 | 8 |
3.390 | 11390 | 10 |
3.400 | 36434 | 12 |
3.410 | 4745 | 6 |
3.420 | 4477 | 5 |
Last trade - 15.56pm 15/07/2024 (20 minute delay) ? |
Featured News
NXL (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online